Preventive Services Task Force. Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement, Ann Intern Med, vol.160, issue.6, pp.414-434, 2014. ,
Gestational diabetes: Linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome, Semin Perinatol, vol.39, issue.4, pp.254-262, 2015. ,
Gestational Diabetes, Obstet Gynecol Clin North Am, vol.44, issue.2, pp.207-224, 2017. ,
Hyperglycemia in pregnancy: prevalence, impact, and management challenges, Int J Womens Health, vol.8, pp.519-546, 2016. ,
Safety of Glyburide for Gestational Diabetes: A Meta-Analysis of Pregnancy Outcomes, Ann Pharmacother, vol.42, issue.4, pp.483-90, 2008. ,
Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. Hribal ML, editor. PLoS One, vol.9, p.109985, 2014. ,
The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis, Adv Med Sci, vol.59, issue.1, pp.95-101, 2014. ,
Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis, vol.12, p.182488, 2017. ,
Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials, J Clin Endocrinol Metab, vol.100, issue.5, pp.2071-80, 2015. ,
Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis, BMJ, 2015. ,
Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes, JAMA, vol.319, issue.17, p.1773, 2018. ,
A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus, N Engl J Med, vol.343, issue.16, pp.1134-1142, 2000. ,
Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice. Clin Pharmacol Ther, vol.85, pp.607-621, 2009. ,
Glyburide transport across the human placenta, Obstet Gynecol, vol.125, issue.3, pp.583-591, 2015. ,
Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management, J Clin Res Pediatr Endocrinol, vol.4, issue.4, pp.169-81, 2012. ,
Determination of glibenclamide and puerarin in rat plasma by UPLC-MS/MS: application to their pharmacokinetic interaction study, Talanta, vol.30, pp.109-124, 2013. ,
Determination of the ratio of serum concentrations of tobramycin between fetus and mother at birth. A model of small scale pharmacokinetics ,
, Arch Fr Pediatr, vol.48, issue.8, pp.543-550, 1991.
Multivariable model-building. A pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables, 2008. ,
Stata Statistical Software: Release 14. College Station, 2015. ,
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus, Expert Opin Drug Metab Toxicol, vol.12, issue.6, pp.691-700, 2016. ,
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents, Clin Pharm, vol.3, issue.5, pp.473-85, 1984. ,
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers, Clin Pharmacol Ther, vol.71, issue.4, pp.286-96, 2002. ,
Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety, Am J Obstet Gynecol, vol.195, issue.1, pp.270-274, 2005. ,
Breast Cancer Resistance Protein: Mediating the Trans-placental Transfer of Glyburide across the Human Placenta, Placenta, vol.29, issue.1, pp.39-43, 2008. ,
The Role of Placental Breast Cancer Resistance Protein in the Efflux of Glyburide across the Human Placenta, Placenta, vol.29, issue.8, pp.743-750, 2008. ,
Identification of CYP3A7 for glyburide metabolism in human fetal livers, Biochem Pharmacol, vol.92, issue.4, pp.690-700, 2014. ,